RYTM filings
Corporate insider profile
Alastair Garfield Filing Activity
Latest reported as Chief Scientific Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$912,702.90
- Latest transaction
- Aug 13, 2026
Affiliated corporations
Reported company relationships
Transaction history
